Office of New Drug (OND) Research: Seeking Collaborators, Funding Opportunities Available
November 6, 2020 | 1:00 p.m. - 2:30 p.m. Eastern
This webinar is FREE.
REGISTER
This webinar will help participants:
- Provide examples of how regulatory science research is used by the Office of New Drugs to (OND) facilitate drug development or inform policy.
- Identify opportunities for collaborating with and applying for funding from OND’s 21st Century Cures Drug Development Tools Grant Program.
- Locate websites where priority lists and funding opportunities are posted for OND’s Combatting Antibiotic-Resistant Bacteria (CARB) Program.
- Distinguish between FDA’s Broad Agency Announcement (BAA) and the Centers of Excellence in Regulatory Science and Innovation (CERSI) Programs.
- Describe the types of candidates who are eligible for FDA’s Oak Ridge Institute for Science and Education (ORISE) Fellowship Program.
INTENDED AUDIENCE
- Biomedical researchers working on topics in the area of drug development tools (e.g., pre-clinical and clinical biomarkers, animal models, clinical outcomes assessments, patient reported outcomes).
- Federal partners who conduct biomedical research as part of their mission (CDC, NIH/NCAATS, etc.).
- Professional development programs at accredited U.S. colleges or universities that award science, technology, engineering, and/or math degrees
- Non-profit organizations who collaborate with FDA
- Scientific professional development groups who collaborate with FDA
- Science, mathematics, or engineering college students (currently enrolled in an accredited U.S. college or university) or post-graduates looking for opportunities to participate in research-based professional development opportunities at FDA.
- Academic program managers for regulatory science graduate degree or certificate awarding programs (e.g., U Maryland, Johns Hopkins, U Southern California, University of Arkansas for Medical Sciences, Northeastern University, Chapman U, Arizona State University UC San Diego).
No hay comentarios:
Publicar un comentario